Accuray Incorporated (NASDAQ: ARAY) and Halifax Health announced a breakthrough in cancer treatment at the Charles L. and Miki N. Grant Cancer Center for Hope in Port Orange, FL. The center's medical team became the first in the United States to treat cancer patients using Accuray's Radixact System with VitalHold technology. This innovative system is designed to enhance the precision of radiation therapy by improving patient positioning and monitoring throughout the treatment process, offering a new standard of care for a wide range of cancer cases, including breast cancer. Significance of Radixact Per Accuray, Radixact System, backed by VitalHold and other advanced technologies like ClearRT helical CT imaging and Synchrony real-time adaptive delivery, represents a significant advancement in radiotherapy. VitalHold's surface-guided radiotherapy (SGRT) ensures accurate patient positioning, improving the reproducibility of treatments and enabling deep inspiration breath hold techniques. This minimizes radiation exposure to critical organs, reducing long-term complications. The system's tattoo-free positioning further enhances patient experience, making radiation therapy more comfortable and cosmetically appealing. The anticipated 35% increase in new cancer cases in the United States by 2040 underscores the critical need for advanced resources. Accuray's Radixact System, equipped with the VitalHold feature, is designed to meet this challenge ...